ABT-072 Uses, Dosage, Side Effects and more
ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C).
| Trade Name | ABT-072 |
| Generic | ABT-072 |
| Type | |
| Formula | C24H27N3O5S |
| Weight | Average: 469.56 Monoisotopic: 469.167142155 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
